Lanreotide
Sold as Somatuline autogel
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 1
- Registrations
- 3
- Schedule source
- SAHPRA documentation
Applicants and registrations
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Somatuline autogel 60 EACH PRE-FILLED SYRINGE CONTAINS LANREOTIDE ACETATE EQUIVALENT TO LANREOTIDE 60,0 mg | 60 mg / 90 mg / 120 mgSolution for injection | 45102245/21.12/1022Approved 16 January 2025 | Registered | S4 | PIPIL |
| Somatuline autogel 90 EACH PRE-FILLED SYRINGE CONTAINS LANREOTIDE ACETATE EQUIVALENT TO LANREOTIDE 90,0 mg | 60 mg / 90 mg / 120 mgSolution for injection | 45102345/21.12/1023Approved 16 January 2025 | Registered | S4 | PIPIL |
| Somatuline autogel 120 EACH PRE-FILLED SYRINGE CONTAINS LANREOTIDE ACETATE EQUIVALENT TO LANREOTIDE 120,0 mg | 60 mg / 90 mg / 120 mgSolution for injection | 45102445/21.12/1024Approved 16 January 2025 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, read from the product's PI-PIL leaflet.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Lanreotide acetate equivalent to lanreotide
S4: Lanreotide
Consolidated Schedules 06 July 2026, line 6852
Pharmacological class: Hormone inhibitors. (class 21.12)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
Schedule Verification
Somatuline autogel 60, Acino Pharma (Pty) Ltd is scheduled S4 in its official SAHPRA documents, read with 90% confidence.
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.